- Accurate determination of malignancy risk is essential in managing patients with indeterminate thyroid nodules (ITNs)
- This real-world study investigates the diagnostic accuracy of a combined oncogene panel and a microRNA classifier/pairwise expression profiler and its impact on treatment decisions
Real-World Study Highlighting the Effectiveness of a Multiplatform Molecular Test in Guiding Management Decisions for Thyroid Nodules with an Indeterminate Cytology Diagnosis
United States and Canadian Academy of Pathology’s 115th Annual Meeting, 2026
Patient management decisions are based on the independent medical judgment of the physician and molecular test results should be taken into consideration in conjunction with all relevant imaging, clinical findings, patient and family history, as well as patient preference.